Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

Press releases published on October 23, 2026

an hour ago

eClinical Solutions Market to Reach USD 25.22 Billion by 2030, Growing at a CAGR of 13.9% – MarketsandMarkets™

Indeterminate GlobeNewswire

an hour ago

GOA Therapeutics Presents New Data at ANESTHESIOLOGY® 2026 for GOA26, a First-in-Class Candidate for Acute Alcohol Intoxication and Poisoning

Indeterminate GlobeNewswire

an hour ago

Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026

Indeterminate GlobeNewswire

an hour ago

How Peptide Conjugate Developability Is Shaped Before a Candidate Is Nominated

Indeterminate GlobeNewswire

an hour ago

Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma

Indeterminate GlobeNewswire

an hour ago

Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026

Indeterminate GlobeNewswire

2 hours ago

XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers

Indeterminate GlobeNewswire

2 hours ago

MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN

Indeterminate GlobeNewswire

2 hours ago

Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress

Indeterminate GlobeNewswire

2 hours ago

Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026

Indeterminate GlobeNewswire

2 hours ago

Celcuity Presents Updated Data from a Phase 1b/2 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration-Resistant Prostate Cancer at the ESMO Congress 2026

Indeterminate GlobeNewswire

2 hours ago

Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer

Indeterminate GlobeNewswire

2 hours ago

Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications

Indeterminate GlobeNewswire

2 hours ago

PRF Technologies Issues Letter to Shareholders Highlighting $11.0 Million Cash Position, Entering Phase 2 Trial of OcuRing™-K and GridFeed™ Opportunity in AI Data Center Power

Indeterminate GlobeNewswire

2 hours ago

Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine

Indeterminate GlobeNewswire

3 hours ago

Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.

Indeterminate GlobeNewswire

3 hours ago

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

Indeterminate GlobeNewswire

3 hours ago

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Indeterminate GlobeNewswire

3 hours ago

Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire

3 hours ago

Gene Synthesis: Technologies and Global Markets to Reach $7.2 Billion by 2031

Indeterminate GlobeNewswire